The last time I spoke about Monte Rosa Therapeutics (NASDAQ:GLUE) it was with respect to a Seeking Alpha article I wrote titled "Monte Rosa: Novartis Deal Bolsters MGD Platform With Flush Of Cash." ...

Data will be presented during Poster Session A on Sunday, November 12, 2023 from 9:00-11:00 am PT BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a ...

CDK2 molecular glue degrader MRT-51443 shows enhanced tumor regression and delayed resistance in breast cancer models, surpassing standard treatments. Details regarding the clinical development ...